Editas Medicine Inc
NASDAQ:EDIT
Income Statement
Earnings Waterfall
Editas Medicine Inc
Revenue
|
78.1m
USD
|
Operating Expenses
|
-247.3m
USD
|
Operating Income
|
-169.2m
USD
|
Other Expenses
|
16m
USD
|
Net Income
|
-153.2m
USD
|
Income Statement
Editas Medicine Inc
Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
1
+394%
|
2
+94%
|
2
+50%
|
6
+132%
|
6
+5%
|
6
+2%
|
6
-2%
|
6
-5%
|
11
+94%
|
14
+25%
|
17
+24%
|
21
+25%
|
29
+39%
|
32
+8%
|
30
-6%
|
25
-17%
|
14
-43%
|
21
+43%
|
24
+18%
|
33
+35%
|
92
+181%
|
91
-1%
|
92
+1%
|
81
-11%
|
25
-70%
|
26
+4%
|
26
+1%
|
32
+23%
|
26
-19%
|
20
-23%
|
23
+16%
|
19
-15%
|
25
+27%
|
78
+217%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||
Operating Expenses |
(24)
|
(29)
|
(37)
|
(50)
|
(62)
|
(77)
|
(103)
|
(116)
|
(123)
|
(133)
|
(134)
|
(138)
|
(156)
|
(153)
|
(146)
|
(144)
|
(134)
|
(142)
|
(161)
|
(180)
|
(185)
|
(200)
|
(226)
|
(237)
|
(250)
|
(242)
|
(219)
|
(213)
|
(218)
|
(230)
|
(246)
|
(249)
|
(235)
|
(233)
|
(247)
|
|
Selling, General & Administrative |
(11)
|
(14)
|
(18)
|
(25)
|
(33)
|
(41)
|
(46)
|
(49)
|
(49)
|
(50)
|
(51)
|
(52)
|
(55)
|
(56)
|
(55)
|
(58)
|
(58)
|
(61)
|
(65)
|
(65)
|
(65)
|
(69)
|
(68)
|
(71)
|
(79)
|
(75)
|
(76)
|
(74)
|
(69)
|
(69)
|
(71)
|
(74)
|
(74)
|
(73)
|
(70)
|
|
Research & Development |
(13)
|
(15)
|
(19)
|
(26)
|
(29)
|
(36)
|
(57)
|
(67)
|
(74)
|
(84)
|
(83)
|
(85)
|
(101)
|
(98)
|
(91)
|
(85)
|
(76)
|
(81)
|
(97)
|
(116)
|
(120)
|
(131)
|
(158)
|
(165)
|
(171)
|
(166)
|
(143)
|
(139)
|
(148)
|
(161)
|
(175)
|
(175)
|
(161)
|
(160)
|
(178)
|
|
Operating Income |
(24)
N/A
|
(28)
-18%
|
(35)
-26%
|
(48)
-36%
|
(57)
-18%
|
(71)
-24%
|
(97)
-38%
|
(110)
-13%
|
(117)
-6%
|
(122)
-5%
|
(120)
+2%
|
(121)
-1%
|
(134)
-11%
|
(124)
+8%
|
(114)
+8%
|
(113)
+0%
|
(109)
+4%
|
(128)
-17%
|
(141)
-10%
|
(156)
-11%
|
(152)
+3%
|
(108)
+29%
|
(135)
-24%
|
(145)
-8%
|
(169)
-17%
|
(217)
-29%
|
(193)
+11%
|
(187)
+3%
|
(186)
+1%
|
(204)
-10%
|
(226)
-11%
|
(226)
0%
|
(216)
+4%
|
(209)
+3%
|
(169)
+19%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
1
|
2
|
3
|
5
|
6
|
7
|
7
|
7
|
5
|
4
|
3
|
1
|
1
|
1
|
2
|
3
|
3
|
5
|
4
|
7
|
11
|
14
|
18
|
|
Total Other Income |
(38)
|
(37)
|
(37)
|
(37)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
7
|
14
|
13
|
16
|
9
|
2
|
3
|
(2)
|
(2)
|
(2)
|
(2)
|
1
|
(0)
|
(0)
|
(0)
|
(2)
|
|
Pre-Tax Income |
(62)
N/A
|
(66)
-7%
|
(73)
-11%
|
(85)
-17%
|
(57)
+33%
|
(70)
-24%
|
(97)
-38%
|
(111)
-14%
|
(118)
-7%
|
(124)
-5%
|
(120)
+3%
|
(120)
+0%
|
(132)
-10%
|
(121)
+9%
|
(110)
+9%
|
(108)
+2%
|
(103)
+5%
|
(121)
-17%
|
(134)
-11%
|
(142)
-6%
|
(132)
+7%
|
(91)
+31%
|
(116)
-27%
|
(135)
-16%
|
(167)
-23%
|
(214)
-28%
|
(193)
+10%
|
(186)
+3%
|
(184)
+1%
|
(201)
-9%
|
(220)
-10%
|
(219)
+1%
|
(206)
+6%
|
(195)
+5%
|
(153)
+21%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(62)
|
(66)
|
(73)
|
(85)
|
(57)
|
(70)
|
(97)
|
(111)
|
(118)
|
(124)
|
(120)
|
(120)
|
(132)
|
(121)
|
(110)
|
(108)
|
(103)
|
(121)
|
(134)
|
(142)
|
(132)
|
(91)
|
(116)
|
(135)
|
(167)
|
(214)
|
(193)
|
(186)
|
(184)
|
(201)
|
(220)
|
(219)
|
(206)
|
(195)
|
(153)
|
|
Net Income (Common) |
(62)
N/A
|
(66)
-7%
|
(73)
-11%
|
(86)
-17%
|
(57)
+33%
|
(71)
-24%
|
(97)
-38%
|
(111)
-14%
|
(118)
-7%
|
(124)
-5%
|
(120)
+3%
|
(120)
+0%
|
(132)
-10%
|
(121)
+9%
|
(110)
+9%
|
(108)
+2%
|
(103)
+5%
|
(121)
-17%
|
(134)
-11%
|
(142)
-6%
|
(132)
+7%
|
(91)
+31%
|
(116)
-27%
|
(135)
-16%
|
(167)
-23%
|
(214)
-28%
|
(193)
+10%
|
(186)
+3%
|
(184)
+1%
|
(201)
-9%
|
(220)
-10%
|
(219)
+1%
|
(206)
+6%
|
(195)
+5%
|
(153)
+21%
|
|
EPS (Diluted) |
-1.74
N/A
|
-1.85
-6%
|
-2.05
-11%
|
-3.84
-87%
|
-1.61
+58%
|
-1.98
-23%
|
-3.02
-53%
|
-3.02
N/A
|
-2.88
+5%
|
-2.99
-4%
|
-2.98
+0%
|
-2.61
+12%
|
-2.82
-8%
|
-2.55
+10%
|
-2.33
+9%
|
-2.21
+5%
|
-2.1
+5%
|
-2.42
-15%
|
-2.68
-11%
|
-2.6
+3%
|
-2.38
+8%
|
-1.45
+39%
|
-1.98
-37%
|
-2.04
-3%
|
-2.45
-20%
|
-3.13
-28%
|
-2.85
+9%
|
-2.73
+4%
|
-2.7
+1%
|
-2.94
-9%
|
-3.21
-9%
|
-3.18
+1%
|
-2.88
+9%
|
-2.38
+17%
|
-2.02
+15%
|